Cargando…

Survivin may be a Key Target for Oxaliplatin

Detalles Bibliográficos
Autor principal:	Baek, Moo Jun
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Coloproctology 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998002/ https://www.ncbi.nlm.nih.gov/pubmed/21152222 http://dx.doi.org/10.3393/jksc.2010.26.4.239

Ejemplares similares

ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Baek, Moo-Jun
Publicado: (2015)

Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
por: Sohn, Won Jun, et al.
Publicado: (2010)

Are Electronic Cigarettes Harmful? Mucin May Be the Key
por: Rha, Min-Seok, et al.
Publicado: (2021)

Expression of the survivin-2B splice variant related to the progression of colorectal carcinoma
por: Cho, Gyu-Seok, et al.
Publicado: (2011)

Different Strategies for Treating a Colovesical Fistula
por: Baek, Moo Jun
Publicado: (2015)

Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
por: Mormile, Raffaella
Publicado: (2016)

Hot Water Swallows May Improve Symptoms in Patients With Achalasia
por: Park, Moo In
Publicado: (2012)

Survivin as a Preferential Target for Cancer Therapy
por: Mobahat, Mahsa, et al.
Publicado: (2014)

Survivin: a unique target for tumor therapy
por: Garg, Himani, et al.
Publicado: (2016)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Prognostic Role of MMPs in Colorectal Cancer
por: Baek, Moo-Jun
Publicado: (2011)

Laparoscopic Right Hemicolectomy for Colon Cancer: Technically Feasible and Safe to Perform in Terms of Oncologic Outcomes
por: Baek, Moo Jun
Publicado: (2012)

Preoperative Body Mass Index and Postoperative Complications After Pelvic Exenteration in Recurrent or Locally Advanced Rectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2014)

Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2013)

Does BRAF Mutation and Extracellular Signal Regulated Kinase Expression in Patients With Colorectal Cancer Have Any Prognostic Significance?
por: Baek, Moo Jun
Publicado: (2015)

Physiology May Be the Key: Cardiovascular Risk Stratification in Obstructive Sleep Apnea
por: Singh, Bhajan
Publicado: (2021)

Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury
por: Mizrahi, Jonathan D., et al.
Publicado: (2018)

Limitation and Value of Using the Adenoma Detection Rate for Colonoscopy Quality Assurance
por: Hur, Jun, et al.
Publicado: (2017)

Survivin – biology and potential as a therapeutic target in oncology
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2013)

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005)

Mast Cell May Be the Master Key to Solve the Mystery of Pathogenesis of Irritable Bowel Syndrome
por: Yoon, Hyuk
Publicado: (2016)

Targeting Survivin in Cancer: Novel Drug Development Approaches
por: Groner, Bernd, et al.
Publicado: (2013)

Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma
por: Brun, Sonja N., et al.
Publicado: (2014)

Targeting survivin as a potential new treatment for chondrosarcoma of bone
por: de Jong, Y, et al.
Publicado: (2016)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

ZIC1 acts a tumor suppressor in breast cancer by targeting survivin
por: Han, Wei, et al.
Publicado: (2018)

Application of quantum dots as vectors in targeted survivin gene siRNA delivery
por: Zhao, Jianjiang, et al.
Publicado: (2013)

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma
por: Locke, Frederick L, et al.
Publicado: (2015)

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
por: Tyner, J W, et al.
Publicado: (2012)

Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma
por: CHEN, ZHOUXUN, et al.
Publicado: (2012)

Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors
por: Ferrario, Angela, et al.
Publicado: (2016)

Molecular docking analysis of aplysin analogs targeting survivin protein
por: Shakeel, Eram, et al.
Publicado: (2017)

Targeting survivin sensitizes cervical cancer cells to radiation treatment
por: Zhou, Jing, et al.
Publicado: (2020)

Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome
por: Fangusaro, J R, et al.
Publicado: (2005)

Survivin 2α: a novel Survivin splice variant expressed in human malignancies
por: Caldas, Hugo, et al.
Publicado: (2005)

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
por: Pol, Jonathan G., et al.
Publicado: (2020)

Targeting survivin using a combination of miR-494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth
por: ZHU, JIN, et al.
Publicado: (2016)

Survivin: A novel marker and potential therapeutic target for human angiosarcoma
por: Tsuneki, Masayuki, et al.
Publicado: (2017)

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas
por: Németh, Kinga, et al.
Publicado: (2018)

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
por: Khan, Zakir, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mq4ic4qknb7p27o3j830vbpe53